Which indicators should be analyzed to assess opportunities in the vaccines market?
Key indicators include clinical pipelines, regulatory approvals, immunization schedules, dose volumes, vaccination coverage rates, manufacturing capacity, cold chain constraints, public procurement policies, price per dose, competition between technology platforms, and needs by therapeutic area. These metrics help pharmaceutical companies, investors, suppliers, health authorities, and strategy teams identify the most attractive vaccine segments, anticipate market access risks, and compare competitive positions.